Course Content
01. Heart Failure Pharmacology: The Clinical Logic
You don't currently have access to this content
02. Hemodynamics: Where Heart Failure Drugs Act
You don't currently have access to this content
03. The Pathophysiologic Loop of HFrEF
You don't currently have access to this content
04. Neurohormonal Targets in Heart Failure
You don't currently have access to this content
05. HFrEF: The Four Mortality-Modifying Pillars
You don't currently have access to this content
06. Pillar 1: ACE Inhibitors, ARBs, and ARNIs
You don't currently have access to this content
07. ARNI Mechanism and the 36-Hour Rule
You don't currently have access to this content
08. Pillar 2: Evidence-Based Beta Blockers
You don't currently have access to this content
09. Pillar 3: Mineralocorticoid Receptor Antagonists
You don't currently have access to this content
10. Pillar 4: SGLT2 Inhibitors
You don't currently have access to this content
11. HFmrEF and HFpEF Pharmacology
You don't currently have access to this content
12. Diuretics: Decongestion, Not Disease Modification
You don't currently have access to this content
13. Diuretic Resistance and Sequential Nephron Blockade
You don't currently have access to this content
14. Digoxin: Inotropy With a Narrow Therapeutic Window
You don't currently have access to this content
15. Add-On HFrEF Therapies
You don't currently have access to this content
16. Acute Decompensated Heart Failure: First Classification
You don't currently have access to this content
17. Acute Decompensated HF: Treatment by Hemodynamic Profile
You don't currently have access to this content
18. Inotropes, Vasodilators, and Vasopressors in Acute HF
You don't currently have access to this content
19. Monitoring and Prescribing Safety
You don't currently have access to this content
20. Drugs That Worsen Heart Failure
You don't currently have access to this content
21. Integrated Board-Style Clinical Reasoning
You don't currently have access to this content

